Tuesday, January 15, 2019 1:46:21 PM
What is really interesting for me is the warm and enthusiastic embrace of our technology at the highest levels (Gottlieb!!! the model of what an enlightened, dedicated public servant should be!). It was not Pluristem specific, but it's a good indication of what knowledgeable people expect, and the position this segment of the biotech industry will occupy in the near future. Needless to say that I'm hoping that we will be a major player in that space.
So even if the administrative mechanisms they're putting in place may take a few months to be activated, the interest in cell/regen technologies is there NOW, and should be a factor in moving this technology to the clinic expeditiously.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM